The role of hysteroscopy in the diagnosis of endometrial cancer
Aristotle University of Thessaloniki · 01.01.2026
DOI: 10.26262/heal.auth.ir.375167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aristotle University of Thessaloniki, erschienen am 01.01.2026. Verfasst von Εvangelia Mareti.
Abstract (Originalsprache)
Background
Endometrial cancer is the most common gynecologic malignancy in developed countries. Accurate histologic diagnosis and risk stratification are essential for appropriate management, particularly in women of reproductive age who may be candidates for fertility-sparing treatment. Although dilation and curettage (D&C) has traditionally been considered the reference diagnostic method, its blind nature limits diagnostic accuracy. Hysteroscopy, by allowing direct visualization of the uterine cavity and targeted endometrial biopsy, has emerged as a valuable alternative; however, concerns regarding oncologic safety have historically limited its routine use.
Objective
To critically evaluate the role of hysteroscopy in the diagnosis and treatment of endometrial cancer, with a focus on diagnostic accuracy, safety, technological advances, and its emerging role in fertility-preserving management.
Methods
A narrative review of the literature was conducted, including comparative studies, systematic reviews, meta-analyses, and key cohort studies assessing hysteroscopy versus blind endometrial sampling for endometrial cancer diagnosis. Evidence regarding hysteroscopic safety, peritoneal cytology, long-term oncologic outcomes, and hysteroscopy-assisted conservative treatment strategies was analyzed.
Results
Hysteroscopy demonstrates superior diagnostic performance compared with blind endometrial sampling, with higher sensitivity, specificity, negative predictive value, and sample adequacy, particularly for focal endometrial lesions. It also improves preoperative assessment of tumor histotype and grade. Although hysteroscopy is associated with an increased rate of positive peritoneal cytology, especially when liquid distension media and elevated intrauterine pressures are used, multiple studies and meta-analyses show no negative impact on recurrence rates, disease progression, or survival, particularly in early-stage disease. Emerging evidence supports the integration of hysteroscopic tumor resection with progestin-based therapy in carefully selected patients undergoing fertility-sparing treatment, with encouraging oncologic and reproductive outcomes. Recent technological innovations, including miniaturized instruments and mechanical morcellators, have further improved procedural safety and outpatient feasibility.
Conclusions
When performed under controlled conditions, hysteroscopy is a safe and highly accurate method for the diagnosis of endometrial cancer. Its diagnostic superiority over blind techniques, favorable safety profile, and expanding therapeutic applications support its integration into contemporary endometrial cancer management, including selected fertility-preserving strategies.
Schlagwörter
Zitieren
APA
Mareti, Ε. (2026). The role of hysteroscopy in the diagnosis of endometrial cancer. Aristotle University of Thessaloniki. https://doi.org/10.26262/heal.auth.ir.375167
Vancouver
Mareti Ε. The role of hysteroscopy in the diagnosis of endometrial cancer. Aristotle University of Thessaloniki. 2026. doi:10.26262/heal.auth.ir.375167
BibTeX
@article{Mareti2026,
author = {Mareti, Εvangelia},
title = {The role of hysteroscopy in the diagnosis of endometrial cancer},
journal = {Aristotle University of Thessaloniki},
year = {2026},
doi = {10.26262/heal.auth.ir.375167}
}
EUVIMED